Dennis P West

Grants

Grants per year 2001 2006 2007 2008 2009 2024

• 1 Active
• 75 Finished

Grants per year

Search results

• Active

  Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure

  Lu, K., Miller, S. D. & West, D. P.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/18 → 7/31/24

  Project: Research project

• Finished

  EHR Anticoagulants Pharmacovigilance

  Belknap, S. M. & West, D. P.

  University of Massachusetts Lowell, National Heart, Lung, and Blood Institute

  1/22/18 → 11/30/19

  Project: Research project

  • installation 100%
  • anticoagulants 100%
  • guidelines 100%
  • universities 100%
  • data 100%

• Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure

  West, D. P. & Miller, S. D.

  Case Western Reserve University, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/4/17 → 7/31/18

  Project: Research project

  • drugs 100%
  • mustard 100%
  • Chemotherapeutic Agent 100%
  • Drug 100%
  • Late Effect 100%

• SHF: Small: Collaborative Research: Designing a Programming Language for Patient-Oriented Prescriptions

  Findler, R., Belknap, S. M. & West, D. P.

  National Science Foundation

  9/1/15 → 8/31/18

  Project: Research project

  • computers 100%
  • patients 100%
  • programming languages 100%
  • Programming Language 100%
  • Computer Science 100%

• Domain-Specific Language Design for Patient-Oriented Prescriptions

  Belknap, S. M., West, D. P. & West, D. P.

  National Science Foundation

  9/1/15 → 8/31/18

  Project: Research project

  • computers 100%
  • patients 100%
  • design 100%
  • Domain-Specific Language 100%
  • Design Language 100%

• EHR Anticoagulants Pharmacovigilance

  Belknap, S. M. & West, D. P.

  University of Massachusetts Medical School, National Heart, Lung, and Blood Institute

  12/1/14 → 11/30/18

  Project: Research project

  • installation 100%
  • anticoagulants 100%
  • guidelines 100%
  • universities 100%
  • data 100%

• EMR Adverse Drug Event Detection for Pharmacovigilance

  Belknap, S. M. & West, D. P.

  University of Massachusetts Medical School, National Cancer Institute

  9/1/14 → 8/31/17

  Project: Research project

  • installation 100%
  • guidelines 100%
  • universities 100%
  • data 100%
  • signals 100%

• Prot #JB121410: Videocapillaroscopy Assessment During Systemic Agent Therapy in Patients with Psoriasis

  Brieva, J. C., Gordon, K. B. & West, D. P.

  AbbVie Inc.

  11/20/13 → 11/20/21

  Project: Research project

• Dermatology Subproject for SHF: Small: Collaborative Research: Designing a Patient-Oriented Prescription Language: An Executable Specification for a Medical Algorithm for Gestational Diabetes Mellitus

  Belknap, S. M., Metzger, B. E., Peaceman, A. M., Spring, B. & West, D. P.

  National Science Foundation

  9/1/12 → 8/31/16

  Project: Research project

• 2012 National Psorasis Foundation Fellowship Program

  Paller, A., Gordon, K. B. & West, D. P.

  National Psoriasis Foundation

  7/1/12 → 6/30/13

  Project: Research project

• Prot# CNTO1959PSO2001: A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (X-PLORE)

  Gordon, K. B., Laumann, A. E. & West, D. P.

  Parexel, Janssen Research & Development, LLC

  5/4/12 → 5/4/15

  Project: Research project

• Off-Label Use of Proteasome Inhibitor Bortezomib in Dermatology

  Budunova, I. & West, D. P.

  Northwestern Memorial Foundation

  1/1/12 → 12/31/13

  Project: Research project

• Prot# SHP-141-001: A Randomized, Double-blind, Placebo-Controlled, Dose-Escalating, Phase 1B Study to Assess the Safety, Pharmacodynamics and Pharmacokinetics of SHP-141, A Histone Deacetylase Inhibitor, Administered Topically up to 28 Days to Patients wi

  Guitart, J., Pedram, G. & West, D. P.

  Therapeutics, Inc., Shape Pharmaceuticals, Inc.

  10/4/11 → 10/4/14

  Project: Research project

• Atopic Dermatitis Research Network (ADRN)

  Paller, A., West, D. P. & West, D. P.

  National Jewish Health, National Institute of Allergy and Infectious Diseases

  7/1/11 → 6/29/15

  Project: Research project

• Prot#R668-AD-0914: A Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending, Repeated-Dose Study of the Safety and Pharmacokinetics of Subcutaneous REGN668 in Patients with Moderate-to-Severe Extrinsic Atopic Dermatitis

  Laumann, A. E., Paller, A. & West, D. P.

  Ingenix Pharmaceutical Services, Inc., Regeneron Pharmaceuticals, Inc.

  2/1/11 → 2/1/14

  Project: Research project

• Prot# SHH4812g: A Phase II, Multicenter, Open Label, Two-Cohort Trial Evaluating The Efficacy And Safety of GDC-0449 In Operable Basal Cell Carcinoma (BCC). DNA Repository Substudy in Association With GDC-0449 Study SHH4812g.

  Yoo, S. S., Alam, M. & West, D. P.

  PPD Development, Genentech, Inc.

  1/13/11 → 1/13/14

  Project: Research project

• Prot# MA-082510: Tolerability Study of Application of a 3M Microstructure Transdermal System by Finger Pressure to the Face in Healthy Subjects Stratified by Age and Fitzpatrick Skin Type

  Alam, M. & West, D. P.

  3M Company and 3M Innovative Properties Co.

  12/13/10 → 12/31/11

  Project: Research project

• Prot# CC-11050-CLE-002: A Phase 2, Pilot, Multicenter, Sequential, Ascending Dose Study to Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects with Discoid Lupus Erythematosus and Subacut

  Laumann, A. E. & West, D. P.

  Celgene Corporation

  12/8/10 → 12/8/13

  Project: Research project

• Treatment of Onychomycosis with Red-light Photodynamic Therapy

  West, D. P.

  American Society for Dermatologic Surgery

  11/11/10 → 11/10/11

  Project: Research project

• Prot# V00400 SB 201: A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants with Proliferating Infantile hemangiomas Requiring Systemic Therapy to Compare Four Regimens of Propranolol (1 or 3 mg/kg/day for 3 or 6 months)

  Mancini, A. J. & West, D. P.

  Ann & Robert H. Lurie Children’s Hospital of Chicago, Pierre Fabre Laboratories

  3/29/10 → 3/29/14

  Project: Research project

• Development and Validation of a Health-Related Quality of Life Instrument for Vitiligo

  Kundu, R. V. & West, D. P.

  Skin of Color Society

  2/1/10 → 1/31/13

  Project: Research project

• PROT# MEL-041509: Phase II Randomized, Double-Blind, Placebo-Controlled, Three-Arm,Dose-Finding, Study to Evaluate the Safety and Efficacy of Erlotinib in the Treatment of Moderate to Severe Psoriasis

  Laumann, A. E., Singri, P. & West, D. P.

  OSI Pharmaceuticals, Inc.

  10/7/09 → 10/7/12

  Project: Research project

• Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals with Severe Neurological Disorders

  Laumann, A. E. & West, D. P.

  Georgia Institute of Technology, National Institute of Biomedical Imaging and Bioengineering

  9/30/09 → 8/31/12

  Project: Research project

• Prot# MCB 0501 INT: Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (aged 12 to 17 years) With Psoriasis Vulgaris

  Paller, A., Lio, P. A. & West, D. P.

  Health Decisions Inc., LEO Pharma A/S

  5/28/09 → 5/28/15

  Project: Research project

• Prot# BAP01346: Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy

  Laumann, A. E., Dago, P. L., Martini, M. C. & West, D. P.

  Covance Periapproval Services, Inc., Basilea Pharmaceutica International Ltd.

  5/26/09 → 5/26/12

  Project: Research project